查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1829708

2025年全球血球比容測量設備市場報告

Hematocrit Test Devices Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，血球比容測量設備市場規模強勁成長，從2024年的46.3億美元增加至2025年的49.1億美元，複合年成長率為6.0%。這段歷史時期的成長歸因於人們對貧血、鐵和維生素缺乏症認知的不斷提高、慢性病盛行率的上升、政府資金的激增以及人口的成長。

預計未來幾年，血球比容測量設備市場規模將強勁成長，2029年將達到61.9億美元，年複合成長率（CAGR）為6.0%。預測期內的成長歸因於貧血盛行率的上升、血液疾病病例的增加、老年人口的成長、人們對健康和健身的日益關注以及對心血管診斷設備的需求的不斷成長。預測期內的主要趨勢包括尖端解決方案的引入、醫療技術的進步、高效創新新產品的研發、血球比容檢測技術的進步以及醫療保健領域的進步。

血球比容測量儀是一種用於測量人體總血容量中紅血球 (RBC) 百分比的醫療設備。此類設備用途廣泛，包括慢性疾病監測、術前評估、血液興奮劑檢測、捐血篩檢、緊急管理以及進行研究和臨床試驗。

血球比容測量設備的主要類型包括血球比容儀、血球比容測量分析儀以及試劑和耗材。血球比容儀 (HCT) 是一種用於測量全血中紅血球百分比的照護現場設備。它們廣泛應用於各種終端使用者環境，包括醫院、門診手術中心、診所以及診斷和病理實驗室，用於治療貧血、真性紅血球增多症和先天性心臟疾病等疾病。

2025年春季，美國關稅突然上調及其引發的貿易摩擦對醫療設備產業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰進一步加劇了形勢，因為由於關稅而更換供應商通常需要醫療設備重新認證，導致市場准入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供血細胞比容計量裝置的市場統計數據，例如全球市場規模、區域佔有率、競爭對手的市場佔有率、詳細的血細胞比容計量裝置細分市場、市場趨勢和商機，以及您在血細胞比容計量裝置行業取得成功所需的數據。本血球比容計量裝置市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切觀點。

我們預測未來五年該市場將成長6.0%，較先前預測略有下降0.6%。下降主要源自於美國與其他國家之間關稅的影響。這可能會透過對來自墨西哥和巴西等主要地區的微量血細胞比容毛細管和高速離心機轉子徵收關稅直接影響美國，從而導致貧血篩檢下降，血液疾病診斷成本上升。由於互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響，這種影響可能會更加廣泛。

預計血液疾病發生率的上升將在未來幾年推動血球比容測量設備市場的擴張。血液疾病包括影響人體血液各種成分的疾病，例如紅血球、白血球、血小板和血漿。由於遺傳因素、環境污染和生活方式改變等多種因素，這些疾病變得越來越普遍。血球比容測量設備在測量全血中紅血球的體積分數方面發揮關鍵作用，為了解患者的血液健康狀況提供了重要的資訊。例如，美國癌症協會於 2024 年 1 月發布的一份報告預測，2024 年美國將新患者，估計死亡人數為 23,670 人。其中，預計新增急性骨髓性白血病(AML) 病例約 20,800 例，主要影響成年患者，約 11,220 人死於 AML。因此，血液疾病發生率的不斷上升刺激了血球比容測量設備市場的成長。

血球容積比檢測設備市場的主要企業正在創新提供血球定量和定性資訊的產品線，例如全血球計數 (CBC) 血液學分析儀。全血球計數 (CBC) 血液學分析儀是用於測量和分析各種血液成分的自動化儀器，包括紅血球 (RBC)、白血球 (WBC) 和血小板。例如，2022 年 3 月，中國醫療設備公司邁瑞醫療國際有限公司推出了 BC-700 血液學分析儀系列。該系列涵蓋全血球計數 (CBC) 和紅血球沉積速率(ESR) 測試，專為中型實驗室設計，其先進的診斷技術可與高級產品相媲美。 BC-700 系列包括 BC-720、BC-760 和 BC-780 等型號，是高階 BC-6000 系列的更緊湊版本，並配備了邁瑞的 SF-Cube 3D 分析技術。 SF Cube 技術利用螢光和雙角度雷射散射訊號對目標細胞進行3D分析。

2023年6月，美國包裝食品製造商瑪氏公司（Mars, Incorporated）以13億美元收購了赫斯卡公司（Heska Corporation）。此次收購後，赫斯卡成為瑪氏寵物護理公司科學與診斷部門的一部分，擴大了其在診斷和技術領域的影響力。此次整合將加速研發，並提升全球寵物醫療保健解決方案的可近性。赫斯卡公司專注於製造血球容積比測量設備。

血球比容測量設備市場包括血球比容離心機、試紙、毛細管傳輸管和適配器套件的銷售。該市場的價值是指“出廠價”，即商品製造商或創造者銷售給其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接銷售給最終客戶的價值。該市場中的商品價值還包括商品創造者銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球血球比容測量設備：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球血球比容儀市場：成長率分析
  • 全球血球比容計量裝置市場表現：規模與成長，2019-2024
  • 全球血球比容計量裝置市場預測：規模與成長，2024-2029年，2034年
  • 全球血球比容測量設備：總目標市場（TAM）

第6章 市場細分

  • 全球血球比容測量設備市場：按產品、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 血球比容測定儀
  • 血球容積比檢測儀
  • 試劑和耗材
  • 全球血球比容計量裝置市場：按應用、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 貧血
  • 真性紅血球增多症
  • 先天性心臟疾病
  • 其他用途
  • 全球血球比容測量設備市場：按最終用戶、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院及門診手術中心
  • 診所
  • 診斷和病理實驗室
  • 其他最終用戶
  • 全球血球容積比測量設備市場：依血球容積比測試儀類型、表現與預測細分，2019-2024 年、2024-2029 年、2034 年
  • 手持式血球比容儀
  • 可攜式血球容積比儀
  • 桌上型血球比容儀
  • 照護現場血球比容儀
  • 數位血球比容計
  • 電池供電的血球容積比儀
  • 全球血球比容測量設備市場：細分血球容積比測試設備（按類型）、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 自動血球容積比分析儀
  • 桌上型血球比容分析儀
  • 半自動血球容積比分析儀
  • 微量血球容積比分析儀
  • 高通量血球容積比分析儀
  • 緊湊型血球比容分析儀
  • 全球血球比容計量裝置市場：按試劑和耗材（按類型）細分，實際和預測，2019-2024 年、2024-2029 年、2034 年
  • 血球測試紙
  • 血球比容移液管和毛細管
  • 用於血球容積比測試的血液檢體採集管
  • 血球容積比檢測品管試劑
  • 血球比容測量設備的校正標準
  • 一次性檢測套組及耗材

第7章 區域和國家分析

  • 全球血球容積比測量設備市場：區域、現況及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球血球容積比測量設備市場：依國家/地區、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 血球比容測量設備市場：競爭格局
  • 血球比容測量設備市場：公司簡介
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Danaher Corporation
  • Siemens Healthcare GmbH
  • Becton, Dickinson and Company（BD）
  • Terumo Corporation
  • Beckman Coulter Inc.
  • Mindray Medical International Limited
  • bioMerieux SA
  • Sysmex Corporation
  • Horiba Ltd.
  • Nihon Kohden Corporation
  • Erba Mannheim
  • Heska Corporation
  • EKF Diagnostics Holding Plc.
  • Nova Biomedical Corporation
  • Boule Diagnostics AB

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029 年血球容積比測量設備市場：提供新機會的國家
  • 2029 年血球容積比測量設備市場：細分市場帶來新機會
  • 2029 年血球比容測量設備市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r30370u

Hematocrit test devices are medical instruments utilized to measure the percentage of red blood cells (RBCs) in a person's total blood volume. These devices serve various purposes, including monitoring chronic conditions, preoperative assessments, detecting blood doping, screening blood donors, managing emergencies, and conducting research and clinical trials.

The primary types of hematocrit test devices include hematocrit test meters, hematocrit test analyzers, and reagents and consumables. A hematocrit (HCT) test meter is a point-of-care device employed to measure the percentage of red blood cells in whole blood. It finds applications in conditions such as anemia, polycythemia vera, congenital heart diseases, among others, and is utilized by various end-users, including hospitals and ambulatory surgical centers, clinics, diagnostic and pathology labs, among others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The hematocrit test devices market research report is one of a series of new reports from The Business Research Company that provides hematocrit test devices market statistics, including hematocrit test devices industry global market size, regional shares, competitors with a hematocrit test devices market share, detailed hematocrit test devices market segments, market trends and opportunities, and any further data you may need to thrive in the hematocrit test devices industry. This hematocrit test devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hematocrit test devices market size has grown strongly in recent years. It will grow from $4.63 billion in 2024 to $4.91 billion in 2025 at a compound annual growth rate (CAGR) of 6.0%. The growth in the historic period can be attributed to a rise in awareness regarding anemia, lack of iron and vitamins, increased incidence of chronic illnesses, the surge in government funding, and increase in the population.

The hematocrit test devices market size is expected to see strong growth in the next few years. It will grow to $6.19 billion in 2029 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to increasing prevalence of anemia, growing cases of blood disorders, rise in geriatric population, growth in focus on health and fitness, and widening need for cardiovascular diagnostic equipment. Major trends in the forecast period include the introduction of cutting-edge solutions, advancement of technology in medical science, creation of new efficient and innovative products, technical developments in hematocrit testing, and advancements in the healthcare sector.

The forecast of 6.0% growth over the next five years reflects a modest reduction of 0.6% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on microhematocrit capillary tubes and high-speed centrifuge rotors, sourced from key regions such as Mexico and Brazil, which could lead to compromised anemia screening and increased costs for blood disorder diagnostics.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing instances of blood disorders are anticipated to drive the expansion of the hematocrit test devices market in the coming years. Blood disorders encompass conditions affecting the various components of human blood, such as red blood cells, white blood cells, platelets, and plasma. These disorders are becoming more prevalent due to a combination of factors including genetic factors, environmental pollution, and changes in lifestyle. Hematocrit test devices play a vital role in measuring the volume percentage of red blood cells in whole blood, offering essential insights into the patient's hematological well-being. For example, a report published by the American Cancer Society in January 2024 projects approximately 62,770 new cases of leukemia in the United States for 2024, leading to an estimated 23,670 deaths. Among these cases, around 20,800 new instances of acute myeloid leukemia (AML) are expected, predominantly affecting adults, with approximately 11,220 deaths attributed to AML, primarily occurring in adult patients. Thus, the rising occurrences of blood disorders are stimulating the growth of the hematocrit test devices market.

Leading companies in the hematocrit test device market are innovating their product offerings, such as complete blood count (CBC) hematology analyzers, to deliver both quantitative and qualitative information about blood cells. A complete blood count (CBC) hematology analyzer is an automated instrument utilized to measure and analyze various components of blood, including red blood cells (RBCs), white blood cells (WBCs), and platelets. For instance, in March 2022, Mindray Medical International Limited, a China-based medical device company, introduced the BC-700 hematology analyzer series. This series encompasses both complete blood count (CBC) and erythrocyte sedimentation rate (ESR) tests, catering to medium-volume laboratories with advanced diagnostic technologies akin to premium products. The BC-700 Series, including models such as BC-720, BC-760, and BC-780, is a more compact iteration of the high-end BC-6000 Series, featuring Mindray's SF Cube 3D analysis technology. Leveraging fluorescence and bi-angular laser scatter signals, the SF Cube technology enables three-dimensional analysis of target cells.

In June 2023, Mars Incorporated, a US-based packaged food products manufacturer, acquired Heska Corporation for $1.3 billion. With this acquisition, Heska now operates under Mars Petcare's Science & Diagnostics division, expanding its reach in diagnostics and technology. The integration facilitates accelerated research and development efforts while enhancing global access to pet healthcare solutions. Heska Corporation specializes in manufacturing hematocrit test devices.

Major companies operating in the hematocrit test devices market are F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthcare GmbH, Becton, Dickinson and Company (BD), Terumo Corporation, Beckman Coulter Inc., Mindray Medical International Limited, bioMerieux SA, Sysmex Corporation, Horiba Ltd., Nihon Kohden Corporation, Erba Mannheim, Heska Corporation, EKF Diagnostics Holding Plc., Nova Biomedical Corporation, Boule Diagnostics AB, Stanbio Laboratory Lp, Drucker Diagnostics, A. Menarini Diagnostics Srl, Sensa Core, Mikroscan Technologies Inc.

North America was the largest region in the hematocrit test devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hematocrit test devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the hematocrit test devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hematocrit test devices market consists of sales of hematocrit centrifuges, test strips, capillary transfer tubes, and adapter kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hematocrit Test Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hematocrit test devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hematocrit test devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hematocrit test devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Hematocrit Test Meter; Hematocrit Test Analyzer; Reagents And Consumables
  • 2) By Application: Anemia; Polycythemia Vera; Congenital Heart Diseases; Other Applications
  • 3) By End-User: Hospitals And Ambulatory Surgical Centers; Clinics; Diagnostic And Pathology Labs; Other End-Users
  • Subsegments:
  • 1) By Hematocrit Test Meter: Handheld Hematocrit Meters; Portable Hematocrit Meters; Desktop Hematocrit Meters; Point-Of-Care Hematocrit Meters; Digital Hematocrit Meters; Battery-Powered Hematocrit Meters
  • 2) By Hematocrit Test Analyzer: Automated Hematocrit Analyzers; Benchtop Hematocrit Analyzers; Semi-Automated Hematocrit Analyzers; Microhematocrit Analyzers; High-Throughput Hematocrit Analyzers; Compact Hematocrit Analyzers
  • 3) By Reagents And Consumables: Hematocrit Test Strips; Hematocrit Pipettes And Capillaries; Blood Sample Collection Tubes For Hematocrit Testing; Quality Control Reagents For Hematocrit Testing; Calibration Standards For Hematocrit Devices; Disposable Test Kits And Consumables
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Bayer AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthcare GmbH; Becton, Dickinson and Company (BD); Terumo Corporation; Beckman Coulter Inc.; Mindray Medical International Limited; bioMerieux SA; Sysmex Corporation; Horiba Ltd.; Nihon Kohden Corporation; Erba Mannheim; Heska Corporation; EKF Diagnostics Holding Plc.; Nova Biomedical Corporation; Boule Diagnostics AB; Stanbio Laboratory Lp; Drucker Diagnostics; A. Menarini Diagnostics Srl; Sensa Core; Mikroscan Technologies Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Hematocrit Test Devices Market Characteristics

3. Hematocrit Test Devices Market Trends And Strategies

4. Hematocrit Test Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Hematocrit Test Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Hematocrit Test Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Hematocrit Test Devices Market Growth Rate Analysis
  • 5.4. Global Hematocrit Test Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Hematocrit Test Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Hematocrit Test Devices Total Addressable Market (TAM)

6. Hematocrit Test Devices Market Segmentation

  • 6.1. Global Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hematocrit Test Meter
  • Hematocrit Test Analyzer
  • Reagents And Consumables
  • 6.2. Global Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Anemia
  • Polycythemia Vera
  • Congenital Heart Diseases
  • Other Applications
  • 6.3. Global Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Ambulatory Surgical Centers
  • Clinics
  • Diagnostic And Pathology Labs
  • Other End-Users
  • 6.4. Global Hematocrit Test Devices Market, Sub-Segmentation Of Hematocrit Test Meter, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Handheld Hematocrit Meters
  • Portable Hematocrit Meters
  • Desktop Hematocrit Meters
  • Point-Of-Care Hematocrit Meters
  • Digital Hematocrit Meters
  • Battery-Powered Hematocrit Meters
  • 6.5. Global Hematocrit Test Devices Market, Sub-Segmentation Of Hematocrit Test Analyzer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Automated Hematocrit Analyzers
  • Benchtop Hematocrit Analyzers
  • Semi-Automated Hematocrit Analyzers
  • Microhematocrit Analyzers
  • High-Throughput Hematocrit Analyzers
  • Compact Hematocrit Analyzers
  • 6.6. Global Hematocrit Test Devices Market, Sub-Segmentation Of Reagents And Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hematocrit Test Strips
  • Hematocrit Pipettes And Capillaries
  • Blood Sample Collection Tubes For Hematocrit Testing
  • Quality Control Reagents For Hematocrit Testing
  • Calibration Standards For Hematocrit Devices
  • Disposable Test Kits And Consumables

7. Hematocrit Test Devices Market Regional And Country Analysis

  • 7.1. Global Hematocrit Test Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Hematocrit Test Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Hematocrit Test Devices Market

  • 8.1. Asia-Pacific Hematocrit Test Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Hematocrit Test Devices Market

  • 9.1. China Hematocrit Test Devices Market Overview
  • 9.2. China Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Hematocrit Test Devices Market

  • 10.1. India Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Hematocrit Test Devices Market

  • 11.1. Japan Hematocrit Test Devices Market Overview
  • 11.2. Japan Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Hematocrit Test Devices Market

  • 12.1. Australia Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Hematocrit Test Devices Market

  • 13.1. Indonesia Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Hematocrit Test Devices Market

  • 14.1. South Korea Hematocrit Test Devices Market Overview
  • 14.2. South Korea Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Hematocrit Test Devices Market

  • 15.1. Western Europe Hematocrit Test Devices Market Overview
  • 15.2. Western Europe Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Hematocrit Test Devices Market

  • 16.1. UK Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Hematocrit Test Devices Market

  • 17.1. Germany Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Hematocrit Test Devices Market

  • 18.1. France Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Hematocrit Test Devices Market

  • 19.1. Italy Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Hematocrit Test Devices Market

  • 20.1. Spain Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Hematocrit Test Devices Market

  • 21.1. Eastern Europe Hematocrit Test Devices Market Overview
  • 21.2. Eastern Europe Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Hematocrit Test Devices Market

  • 22.1. Russia Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Hematocrit Test Devices Market

  • 23.1. North America Hematocrit Test Devices Market Overview
  • 23.2. North America Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Hematocrit Test Devices Market

  • 24.1. USA Hematocrit Test Devices Market Overview
  • 24.2. USA Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Hematocrit Test Devices Market

  • 25.1. Canada Hematocrit Test Devices Market Overview
  • 25.2. Canada Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Hematocrit Test Devices Market

  • 26.1. South America Hematocrit Test Devices Market Overview
  • 26.2. South America Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Hematocrit Test Devices Market

  • 27.1. Brazil Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Hematocrit Test Devices Market

  • 28.1. Middle East Hematocrit Test Devices Market Overview
  • 28.2. Middle East Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Hematocrit Test Devices Market

  • 29.1. Africa Hematocrit Test Devices Market Overview
  • 29.2. Africa Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Hematocrit Test Devices Market Competitive Landscape And Company Profiles

  • 30.1. Hematocrit Test Devices Market Competitive Landscape
  • 30.2. Hematocrit Test Devices Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

31. Hematocrit Test Devices Market Other Major And Innovative Companies

  • 31.1. Danaher Corporation
  • 31.2. Siemens Healthcare GmbH
  • 31.3. Becton, Dickinson and Company (BD)
  • 31.4. Terumo Corporation
  • 31.5. Beckman Coulter Inc.
  • 31.6. Mindray Medical International Limited
  • 31.7. bioMerieux SA
  • 31.8. Sysmex Corporation
  • 31.9. Horiba Ltd.
  • 31.10. Nihon Kohden Corporation
  • 31.11. Erba Mannheim
  • 31.12. Heska Corporation
  • 31.13. EKF Diagnostics Holding Plc.
  • 31.14. Nova Biomedical Corporation
  • 31.15. Boule Diagnostics AB

32. Global Hematocrit Test Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hematocrit Test Devices Market

34. Recent Developments In The Hematocrit Test Devices Market

35. Hematocrit Test Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Hematocrit Test Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Hematocrit Test Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Hematocrit Test Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer